A new approach

Activating the immune system
to fight solid tumors.

Cytovation develops treatments
for solid tumors in oncology
and rare diseases.

Activating the immune system
to fight solid tumors.

Cytovation develops treatments
for solid tumors in oncology
and rare diseases.

Developing Programs

AGENT: CyPep-1 // MONOTHERAPY | ALL COMERS | Ph I/II

STATUS: Enrolling | SPONSOR: Cytovation

AGENT: CyPep-1 // MONOTHERAPY | LIVER | Ph I

STATUS: Initiate 2H – 21 | SPONSOR: Cytovation

AGENT: CyPep-1 + Pembrolizumab // COMBINATION | ALL COMERS | Ph I

STATUS: Initiate 2H – 22 | SPONSOR: Cytovation | COLLABORATOR: Merck

AGENT: CyPep-1 + Pembrolizumab // COMBINATION | MELANOMA | Ph II

STATUS: Initiate 2H – 22 | SPONSOR: Cytovation | COLLABORATOR: Merck

AGENT: CyPep-1 + Pembrolizumab // COMBINATION | HNSCC | Ph II

STATUS: Initiate 2H – 22 | SPONSOR: Cytovation | COLLABORATOR: Merck

AGENT: CyPep-1 + Pembrolizumab // COMBINATION | TNBC | Ph II

STATUS: Initiate 2H – 22 | SPONSOR: Cytovation | COLLABORATOR: Merck

AGENT: CYPEP-1 // MONOTHERAPY | RECURRENT RESPIRATORY PAPILLOMATOSIS | PH I/II

STATUS: Initiate 2H – 22 | SPONSOR: Cytovation